Neurocrine Biosciences to Present at the Bank of America 2021 Healthcare Conference

Rhea-AI Summary

Neurocrine Biosciences (Nasdaq: NBIX) will present at the Bank of America 2021 Healthcare Conference on May 11, 2021, at 11:00 a.m. Eastern Time. CEO Kevin Gorman will lead the presentation, which will be webcast live on the company's website. A replay will be available shortly after the event and archived for a month. Neurocrine focuses on developing treatments for neurological, endocrine, and psychiatric disorders, offering FDA-approved therapies for conditions like tardive dyskinesia and Parkinson's disease.

News Market Reaction – NBIX

+0.11%

+0.11% Session move

In the trading session that priced this news, NBIX gained 0.11%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, May 4, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America 2021 Healthcare Conference at 11:00 a.m. Eastern Time on Tuesday May 11, 2021. Kevin Gorman, Chief Executive Officer, will present at the conference.

The live presentation will be webcast and may be accessed on the Company's website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.

About Neurocrine Biosciences

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com, and follow the company on LinkedIn. (*in collaboration with AbbVie)

View original content to download multimedia:http://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-bank-of-america-2021-healthcare-conference-301283667.html

SOURCE Neurocrine Biosciences, Inc.

FAQ

What event will Neurocrine Biosciences present at?

Neurocrine Biosciences will present at the Bank of America 2021 Healthcare Conference on May 11, 2021.

Who will present for Neurocrine Biosciences at the conference?

Kevin Gorman, the CEO, will present for Neurocrine Biosciences at the conference.

What time is Neurocrine Biosciences' presentation at the conference?

The presentation will be held at 11:00 a.m. Eastern Time on May 11, 2021.

Where can I watch the Neurocrine Biosciences presentation?

The presentation will be webcast live and can be accessed on Neurocrine's website under the Investors section.

Will there be a replay of Neurocrine Biosciences' presentation?

Yes, a replay will be available on the website approximately one hour after the presentation and archived for about one month.

What is the stock symbol for Neurocrine Biosciences?

The stock symbol for Neurocrine Biosciences is NBIX.